Our previous studies have demonstrated that overexpression of PIK3CD-S splice variant in PCa confers AA PCa resistance to PI3Kδ inhibitor, such as Idelalisib (32, 33). The gene discussed is PIK3CD; the disease is posterior cortical atrophy.